BlackRock Institutional Trust Company, N.A. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$29,992,000
-17.4%
3,035,630
+1.0%
0.00%
-33.3%
Q3 2016$36,301,000
+47.8%
3,005,011
+5.6%
0.01%
+50.0%
Q2 2016$24,555,000
-9.0%
2,845,357
-0.2%
0.00%0.0%
Q1 2016$26,992,000
-45.9%
2,850,270
-1.0%
0.00%
-50.0%
Q4 2015$49,887,000
+36.7%
2,878,642
+5.9%
0.01%
+33.3%
Q3 2015$36,497,000
-41.5%
2,717,579
-1.7%
0.01%
-40.0%
Q2 2015$62,438,000
+50.4%
2,765,185
-4.9%
0.01%
+66.7%
Q1 2015$41,525,000
+47.7%
2,907,935
-0.2%
0.01%
+50.0%
Q4 2014$28,105,000
+6.3%
2,912,435
+0.3%
0.00%0.0%
Q3 2014$26,428,000
-8.1%
2,904,204
-0.2%
0.00%
-20.0%
Q2 2014$28,746,000
-19.9%
2,909,476
+3.1%
0.01%
-16.7%
Q1 2014$35,867,000
-5.4%
2,823,050
+11.6%
0.01%
-14.3%
Q4 2013$37,915,000
+34.3%
2,529,358
-1.1%
0.01%
+40.0%
Q3 2013$28,225,000
+41.7%
2,556,584
+2.0%
0.01%
+25.0%
Q2 2013$19,919,0002,505,5030.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders